Annual report pursuant to Section 13 and 15(d)

Schedule of Disposal Groups Including Discontinuing Operations from Balance Sheet (Details)

v3.23.1
Schedule of Disposal Groups Including Discontinuing Operations from Balance Sheet (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]    
Accounts receivable $ 11 $ 457
Due from Reaction Biology Corporation 334  
Other current assets 345
Assets of discontinuing operations - current 345 802
Fixed assets, net of accumulated depreciation 163
Operating lease right-of-use assets 30
Patents and other intangible assets, net 8,787
Goodwill 2,164
Other assets 364
Assets of discontinuing operations - non-current 11,508
Accounts payable 47 358
Due to RDDT a vivoPharm Company Pty Ltd 216  
Accrued expense 577 418
Obligation under operating lease, current 29
Obligation under finance lease, current 32
Deferred revenue 43 1,911
Taxes payable 69 365
Other current liabilities 267 409
Liabilities of discontinued operations - current 1,219 3,522
Obligations under operating leases, less current 2
Obligations under finance leases, less current 47
Liabilities of discontinued operations -non- current $ 49